Stock Earnings

Question 1

Rallybio Corpの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Rallybio Corpの総資産は$68で、純lossは$-57です。

Question 2

RLYBの主要な財務比率は何ですか？

Accepted Answer

Rallybio Corpの流動比率は11.33、純利益率は0、1株当たり売上高は$0です。

Question 3

Rallybio Corpの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Rallybio Corp largest revenue segment is Life-transforming Therapies, at a revenue of 636,000 in the most earnings release.For geography, United States is the primary market for Rallybio Corp, at a revenue of 636,000.

Question 4

Rallybio Corpは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Rallybio Corpの純lossは$-57です。

Question 5

Rallybio Corpに負債はありますか？

Accepted Answer

yes、Rallybio Corpの負債は6です。

Question 6

Rallybio Corpの発行済株式数は何株ですか？

Accepted Answer

Rallybio Corpの総発行済株式数は41.51株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	15	19	25	27	18	7
Research & Development	23	41	53	40	26	17
Operating Expenses	38	61	78	67	45	25
Other Non Operating Income (Expenses)	22	0	0	0	0	0
Pretax Income	-14	-57	-74	-66	-47	-26
Income Tax Expense	--	--	--	--	0	0
Net Income	-14	-57	-74	-66	-47	-26
Net Income Growth	-79%	-23%	12%	40%	81%	53%
Shares Outstanding (Diluted)	45.05	43.54	40.44	31.82	25.52	2.66
Shares Change (YoY)	0%	8%	27%	25%	859%	55%
EPS (Diluted)	-0.32	-1.32	-1.84	-2.09	-1.84	-9.95
EPS Growth	-78%	-28%	-12%	14%	-82%	-2%
Free Cash Flow	-35	-49	-60	-57	-45	-22
Free Cash Flow Per Share	-0.77	-1.12	-1.48	-1.79	-1.76	-8.27
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-38	-60	-78	-67	-45	-25
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-38	-60	-78	-67	-45	-25
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	0%	0%

Rallybio Corp (RLYB) Price

RLYB Stock Price Chart

RLYB Income

Follow-Up Questions